source
- Supernus and Indivior announce all-stock merger to create CNS-focused drugmakerSupernus Pharmaceuticals and Indivior Pharmaceuticals have signed an all‑stock merger agreement to combine their businesses. The new company will be dedicated to developing treatments for central…
- Dash Bio secures $30 million Series A funding led by Oak HC/FTDash Bio announced it has closed a $30 million Series A financing round, with Oak HC/FT serving as the lead investor. The capital will be used to expand the company’s platform that offers cloud‑sty…